P&K Skin Research Center Co. Ltd (KQ:347740) — Stock Price
P&K Skin Research Center Co. Ltd (KQ:347740) is currently trading at ₩1823.00 KRW, up 0.61% today. Over the past 52 weeks, shares have ranged between ₩1630.00 and ₩3130.00. This page tracks P&K Skin Research Center Co. Ltd's live share price on the KQ exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see P&K Skin Research Center Co. Ltd (347740) market capitalisation.
P&K Skin Research Center Co. Ltd (347740) Stock Price Chart — Daily History & Trading Volume
The chart below tracks P&K Skin Research Center Co. Ltd's daily closing share price and trading volume on the KQ exchange over the past year, giving a clear view of recent price momentum and liquidity.
P&K Skin Research Center Co. Ltd Income Statement — Revenue, Profit & Earnings by Year
P&K Skin Research Center Co. Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | ₩17.85 Billion | ₩14.84 Billion | ₩17.96 Billion | ₩17.49 Billion | ₩14.68 Billion |
| Cost of Revenue | ₩9.37 Billion | ₩7.64 Billion | ₩6.84 Billion | ₩6.19 Billion | ₩4.35 Billion |
| Gross Profit | ₩8.48 Billion | ₩7.20 Billion | ₩11.11 Billion | ₩11.30 Billion | ₩10.33 Billion |
| Research & Development | ₩1.52 Billion | ₩1.36 Billion | ₩1.67 Billion | ₩1.26 Billion | ₩852.73 Million |
| SG&A | ₩3.95 Billion | ₩4.05 Billion | ₩3.52 Billion | ₩3.32 Billion | ₩2.01 Billion |
| Total Operating Expenses | ₩15.26 Billion | ₩13.46 Billion | ₩12.32 Billion | ₩11.03 Billion | ₩7.46 Billion |
| Operating Income | ₩2.58 Billion | ₩1.38 Billion | ₩5.64 Billion | ₩6.46 Billion | ₩7.22 Billion |
| EBITDA | — | — | — | — | — |
| EBIT | — | — | — | — | ₩7.22 Billion |
| Interest Expense | ₩26.49 Million | ₩32.77 Million | ₩25.77 Million | ₩29.86 Million | ₩22.22 Million |
| Income Before Tax | ₩6.80 Billion | ₩5.36 Billion | ₩8.19 Billion | ₩8.53 Billion | ₩7.78 Billion |
| Income Tax Expense | — | — | — | — | ₩1.06 Billion |
| Net Income | ₩5.82 Billion | ₩4.81 Billion | ₩7.13 Billion | ₩7.29 Billion | ₩6.72 Billion |
P&K Skin Research Center Co. Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes P&K Skin Research Center Co. Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | ₩82.04 Billion | ₩77.41 Billion | ₩74.54 Billion | ₩67.09 Billion | ₩59.89 Billion |
| Total Current Assets | ₩48.16 Billion | ₩51.08 Billion | ₩60.36 Billion | ₩44.02 Billion | ₩51.25 Billion |
| Cash & Equivalents | ₩6.46 Billion | ₩9.80 Billion | ₩4.98 Billion | ₩1.51 Billion | ₩3.89 Billion |
| Short-term Investments | ₩34.25 Billion | ₩34.89 Billion | ₩52.48 Billion | ₩40.74 Billion | ₩45.83 Billion |
| Net Receivables | ₩1.37 Billion | ₩1.67 Billion | ₩1.90 Billion | ₩1.40 Billion | ₩1.01 Billion |
| Inventory | — | — | — | — | — |
| Property, Plant & Equipment | ₩3.64 Billion | ₩4.64 Billion | ₩4.57 Billion | ₩4.62 Billion | ₩2.53 Billion |
| Goodwill | — | — | — | — | — |
| Total Liabilities | ₩5.10 Billion | ₩3.17 Billion | ₩3.73 Billion | ₩4.03 Billion | ₩4.27 Billion |
| Total Current Liabilities | ₩4.75 Billion | ₩2.59 Billion | ₩3.08 Billion | ₩3.12 Billion | ₩3.56 Billion |
| Long-term Debt | — | — | — | — | — |
| Net Debt | — | — | — | — | — |
| Total Stockholder Equity | ₩76.94 Billion | ₩74.20 Billion | ₩70.81 Billion | ₩63.07 Billion | ₩55.63 Billion |
| Retained Earnings | ₩51.41 Billion | ₩46.30 Billion | ₩42.36 Billion | ₩36.13 Billion | ₩28.83 Billion |
P&K Skin Research Center Co. Ltd Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how P&K Skin Research Center Co. Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₩9.03 Billion | ₩5.55 Billion | ₩7.51 Billion | ₩7.70 Billion | ₩8.67 Billion |
| Capital Expenditures | ₩622.12 Million | ₩1.56 Billion | ₩1.36 Billion | ₩2.81 Billion | ₩1.05 Billion |
| Free Cash Flow | ₩8.41 Billion | ₩3.99 Billion | ₩6.15 Billion | ₩4.89 Billion | ₩7.61 Billion |
| Investing Cash Flow | ₩-8.87 Billion | ₩972.22 Million | ₩-4.32 Billion | ₩-9.81 Billion | ₩-37.41 Billion |
| Financing Cash Flow | ₩-3.49 Billion | ₩-1.71 Billion | ₩283.73 Million | ₩-263.72 Million | ₩24.20 Billion |
| Dividends Paid | ₩714.68 Million | ₩872.08 Million | ₩892.93 Million | — | — |
| Stock-Based Compensation | ₩15.84 Million | ₩65.71 Million | ₩65.98 Million | ₩50.14 Million | — |
| Depreciation | ₩1.85 Billion | ₩1.73 Billion | ₩1.47 Billion | ₩1.26 Billion | ₩844.60 Million |
| Change in Cash | ₩-3.34 Billion | ₩4.82 Billion | ₩3.47 Billion | ₩-2.38 Billion | ₩-4.54 Billion |
P&K Skin Research Center Co. Ltd Earnings History — EPS Actual vs. Analyst Estimates
Track P&K Skin Research Center Co. Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Sep 30, 2025 | 55.20 | — | — |
| Jun 30, 2025 | 55.84 | — | — |
| Mar 31, 2025 | 81.56 | — | — |
| Mar 28, 2025 | 37.55 | — | — |
| Sep 30, 2024 | 80.92 | — | — |
| Jun 30, 2024 | 37.41 | — | — |
| Mar 31, 2024 | 44.55 | — | — |
| Mar 28, 2024 | 67.79 | — | — |